Adverse events78

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

61 to 78 of 78

Type	Event	Organ system	Group	Affected	At risk	Events
serious	THROMBOCYTOPENIA	Blood and lymphatic system disorders	OMS721 (Narsoplimab)	1	6	1
serious	RENAL GRAFT INFECTION	Infections and infestations	OMS721 (Narsoplimab)	2	6	2
serious	ESCHERICHIA SEPSIS	Infections and infestations	OMS721 (Narsoplimab)	1	6	2
serious	CEREBRAL HEMATOMA	Nervous system disorders	OMS721 (Narsoplimab)	1	6	2
serious	LEUKOPENIA	Blood and lymphatic system disorders	OMS721 (Narsoplimab)	1	6	1
serious	HAEMOLYSIS	Blood and lymphatic system disorders	OMS721 (Narsoplimab)	2	6	2
serious	CHRONIC ALLOGRAFT NEPHROPATHY	Immune system disorders	OMS721 (Narsoplimab)	1	6	1
serious	KIDNEY TRANSPLANT REJECTION	Immune system disorders	OMS721 (Narsoplimab)	1	6	1
serious	CHRONIC KIDNEY DISEASE	Renal and urinary disorders	OMS721 (Narsoplimab)	1	6	1
serious	ARTERIOVENOUSE FISTULA ANEURYSM	Injury, poisoning and procedural complications	OMS721 (Narsoplimab)	1	6	1
serious	HEPATIC FAILURE	Hepatobiliary disorders	OMS721 (Narsoplimab)	1	6	1
serious	PNEUMONIA	Infections and infestations	OMS721 (Narsoplimab)	1	6	1
serious	URINARY TRACT INFECTION	Infections and infestations	OMS721 (Narsoplimab)	2	6	2
serious	SHUNT BLOOD FLOW EXCESSIVE	Injury, poisoning and procedural complications	OMS721 (Narsoplimab)	1	6	2
serious	PULMONARY HYPERTENSION	Respiratory, thoracic and mediastinal disorders	OMS721 (Narsoplimab)	1	6	1
serious	PURPURA	Skin and subcutaneous tissue disorders	OMS721 (Narsoplimab)	1	6	1
serious	HYPERTENSION	Vascular disorders	OMS721 (Narsoplimab)	1	6	2
serious	Cardiac failure	Cardiac disorders	OMS721 (Narsoplimab)	1	6	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03205995/events?page=4